Sonnet BioTherapeutics Holdings, Inc.
(NASDAQ : SONN)

( )
SONN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.82%72.010.0%$2372.81m
NVAXNovavax, Inc. 4.83%178.5199.2%$1337.92m
SRNESorrento Therapeutics, Inc. 30.51%18.821.8%$899.58m
GILDGilead Sciences, Inc. -1.21%68.511.0%$564.29m
AMGNAmgen, Inc. -1.05%238.171.3%$477.09m
REGNRegeneron Pharmaceuticals, Inc. -1.93%608.242.5%$403.31m
BNTXBioNTech SE -3.96%73.950.0%$397.67m
VRTXVertex Pharmaceuticals, Inc. -1.56%268.731.9%$369.46m
BIIBBiogen, Inc. -1.78%300.261.6%$363.67m
ILMNIllumina, Inc. -0.65%353.353.5%$342.14m
VXRTVaxart, Inc. 2.23%9.400.0%$296.32m
EBSEmergent BioSolutions, Inc. -0.19%130.416.4%$188.70m
ALXNAlexion Pharmaceuticals, Inc. -1.36%101.882.0%$166.53m
IBIOiBio, Inc. -3.16%3.680.2%$166.50m
SGENSeattle Genetics, Inc. -1.71%157.706.0%$160.68m

Company Profile

Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey.